<scp> <i>hURAT1</i> </scp> Transgenic Mouse Model for Evaluating Targeted Urate‐Lowering Agents
The hURAT1-KI hyperuricemia mouse model would be valuable for preclinical evaluation of gout treatment with urate-lowering drugs and for studying UA metabolic complexities in humans.
Authors
- Pei‐Hui Lin (ORCID: https://orcid.org/0000-0002-3894-5099)
- Weiyan Cai (ORCID: https://orcid.org/0000-0002-3772-1819)
- Gejing De (ORCID: https://orcid.org/0000-0001-6099-5052)
- Apeng Chen (ORCID: https://orcid.org/0000-0002-1936-2007)
- Guohua Yi (ORCID: https://orcid.org/0000-0001-8075-5478)
- Miyi Yang (ORCID: https://orcid.org/0000-0002-4444-2113)
- Qinghe Zhao (ORCID: https://orcid.org/0000-0002-1887-9370)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- The University of Texas at Tyler (US)
- The Ohio State University Wexner Medical Center (US)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- The University of Texas Health Science Center at Tyler (US)
Publication Details
- Journal
- International Journal of Rheumatic Diseases
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1111/1756-185x.70034
- Citations
- 1
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.34
Funders
- National Natural Science Foundation of China